Navigation Links
New Data on Cimzia® (certolizumab pegol) to be Presented at ACG Meeting Highlights Role of Inflammatory Biomarkers in Treatment for Moderate to Severe Crohn's Disease
Date:10/31/2011

r antibodies and anti-double stranded DNA antibody formation was low in patients with active CD receiving continuous or interrupted CZP therapy over 52 weeks, regardless of concomitant immunosuppressants use at baseline.  
  • Poster 726, October 31, 12:45 – 2:15 pm, Prince Georges Exhibit Hall

  • Following is a guide to additional Cimzia presentations at ACG:

    • Fecal Calprotectin Concentration and Clinical Remission in Patients with Active Crohn's Disease Treated with Certolizumab Pegol: Results from PRECiSE 1
      • Poster 282, October 30, 3:30 – 7:00 pm, Prince Georges Exhibit Hall

    • Fecal Calprotectin Concentration and Clinical Response to Certolizumab Pegol in Patients with Active Crohn's Disease: Results from PRECiSE 2
      • Poster 711, October 31, 12:45 – 2:15 pm, Prince Georges Exhibit Hall

    • Use of Certolizumab Pegol in the Management of Acute Extraintestinal Manifestations of Active Crohn's Disease
      • Poster 740, October 31, 12:45 – 2:15 pm, Prince Georges Exhibit Hall

    To view a full schedule of presentations and poster sessions, please click here.  To schedule an interview with Cem Kayhan, MD, Medical Director at UCB or PRECiSE investigator, William Sandborn, MD (University of California San Diego, La Jolla, CA) please contact Andrea Levin at (770) 970-8352 or Andrea.Levin@ucb.com.

    About Crohn's Disease

    Crohn's disease is a chronic, progressive, destructive disorder that causes inflammation of the gastrointestinal (GI) tra
    '/>"/>

    SOURCE UCB
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Cimzia® (certolizumab pegol) Data Showed Rapid Improvement in Signs and Symptoms Predicted Better Long-Term Outcomes in Rheumatoid Arthritis Patients
    2. Cimzia® (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients
    3. New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
    4. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
    5. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
    6. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
    7. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
    8. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
    9. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
    10. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
    11. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/5/2015)... 5, 2015 Vermillion, Inc. (Nasdaq: ... on gynecologic disease, announced today it will report ... market open on Wednesday, March 25, 2015, followed ... 8:30am Eastern. Conference Call & Webcast: ... Pacific Domestic: , 800-753-9057International: , 913-981-5571Conference ID: , ...
    (Date:3/5/2015)... , March 5, 2015  As the ... of regulations, Ethics & Compliance professionals are placing ... a new survey issued today by LRN, the ... education. An overwhelming majority of respondents expressed that ... most important component of E&C training programs (57%), ...
    (Date:3/5/2015)... 5, 2015  Sanomedics, Inc. (OTC: SIMH, SIMHD) ("Sanomedics" ... on developing, manufacturing, and acquiring cutting-edge technology, products and ... will be exhibiting at booth # 709 at the ... (NAPNAP) taking place on March 11-13, 2015 at Caesars ... The 36 th annual NAPNAP ...
    Breaking Medicine Technology:Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 2Sanomedics to Showcase the Caregiver at National Association of Pediatric Nurse Practitioners Conference 3
    ... Announces Clinical Trial Plans for 4Q07/1Q08, DALLAS, ... ACCP) provided today an update on the clinical,development ... prodrug, and,announced plans for additional human clinical trials ... ongoing clinical trial in recurrent ovarian,cancer patients, designed ...
    ... ... Study -, ... has initiated a multi-dose, Phase 2a clinical trial with,its monoclonal antibody ... dose-escalation study is,designed to evaluate the safety and tolerability of multiple ...
    Cached Medicine Technology:Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 2Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 3Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 4MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma 2
    (Date:3/5/2015)... York, NY (PRWEB) March 05, 2015 ... move forward in a Pennsylvania mass tort litigation ... Pleas, where a jury has begun hearing testimony ... that the atypical antipsychotic medication can cause gynecomastia, ... the case in question was filed on behalf ...
    (Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to announce ... logo and optimized website. , CNI’s new ... expert diagnostic imaging, centered on patient care. The new ... a resource for Nebraska patients and a tool for ... referral functionality, video content and resources to understand health ...
    (Date:3/5/2015)... HomeCEUConnection.com is proud to support Nutrition ... their nutrition CEUs. To raise awareness on ... is offering 10% off selected nutrition CEU ... . , High Quality Continuing Education for ... continuing education courses for Physical Therapists, Physical ...
    (Date:3/5/2015)... On March 2, 2015, NBC News ... the Rise, Plastic Surgeons Say,” that comments on the ... Aesthetic Plastic Surgery and the American Society ... year-over-year doubling of surgical butt augmentations performed in 2014. ... article, this increase can be attributed to the social ...
    (Date:3/5/2015)... Michigan (PRWEB) March 05, 2015 In ... opportunity to shatter myths about drug and alcohol abuse ... has released a Fact Sheet with information on some ... Launched in 2010 by the National Institute on Drug ... and alcohol aims to counteract the illusions that teens ...
    Breaking Medicine News(10 mins):Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2
    ... are no easy discounts because of where you live or whether ... is totally out of your control.  Here are a few things ... Do the Math: While a plan with a lower premium ... come with either higher co-pays (the part you pay out-of-pocket at ...
    ... CINCINNATI, Dec. 11, 2008 The Procter & Gamble,Company ... Analyst Meeting today in New York City,beginning at 8:30 ... Chief,Executive Officer A.G. Lafley and the Company,s executive management ... and long-term strategies,capabilities and growth opportunities. , ...
    ... Physician and top stress expert advises getting a flu shot and ... ... Nottingham, UK (PRWEB) December 11, 2008 -- During this time of ... combine with the pressures of the holiday season. But top ...
    ... discovered that scientists in Australian were using a skin cancer cream ... benefits to mesothelioma patients. In a majority of the mice, scientists ... ... Denver, CO (PRWEB) December 11, 2008 -- LegalView, the number one ...
    ... of Utah researchers have developed an automobile ignition key that ... messages while driving. , The university has obtained provisional patents ... company that hopes to see it on the market within ... key plus a yet-undetermined monthly service fee. , "The ...
    ... (Nasdaq: ACEL ) today reported its financial results for ... The company recorded a net loss of approximately $2.8 ... fiscal quarter ended Oct. 31., compared to a net loss of ... the first quarter of fiscal 2008. Research and development expenses ...
    Cached Medicine News:Health News:How to Save Money on Health Insurance 2Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 2Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 3Health News:P&G To Share Confidence in Long-Term Strategies and Goals at 2008 Analyst Meeting 4Health News:Don't 'Worry Yourself Sick' This Winter 2Health News:Don't 'Worry Yourself Sick' This Winter 3Health News:LegalView Reports That Skin Cancer Drug May Offer Treatment to Mesothelioma Patients 2Health News:LegalView Reports That Skin Cancer Drug May Offer Treatment to Mesothelioma Patients 3Health News:LegalView Reports That Skin Cancer Drug May Offer Treatment to Mesothelioma Patients 4Health News:Car key jams teen drivers' cell phones 2Health News:Car key jams teen drivers' cell phones 3Health News:Car key jams teen drivers' cell phones 4Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 2Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 3Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 4Health News:Alfacell Reports Financial Results for First Quarter of Fiscal 2009 5
    ... Artis dTC is a versatile solution designed ... department from preparation to diagnosis and ... With AXIOM Artis dTC, your cath lab ... department that leaves you free to concentrate ...
    ... BC is a biplane cardiovascular ... ideal for cardiological diagnostics and ... architecture enables you to optimally ... focus on:, Interventional cardiology, ...
    MAGNETOM Symphony, an imaging system that offers 1.5T performance and top image quality in a short bore design....
    ... you to scan every beating heart at any ... possible. A scanner using two X-ray sources ... provides one-stop diagnosis in acute care; even with ... Combined with the Cardiac Engine, a unique combination ...
    Medicine Products: